Detalles de la búsqueda
1.
Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical Setting
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267703
2.
Plasma neutralization properties of the SARS-CoV-2 Omicron variant
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267646
3.
A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-422693
4.
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21255596
5.
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20169128
6.
SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270692
7.
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259939
8.
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434227
9.
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-092619
Resultados
1 -
9
de 9
1
Próxima >
>>